We are live on ! Find out more
PC

PA Capital Portfolio holdings

AUM $142M
1-Year Est. Return 46.45%
This Fund
S&P 500
This Quarter Est. Return
+16.43%
1 Year Est. Return
+46.45%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$142M
AUM Growth
+$4.26M
Cap. Flow
-$10.9M
Cap. Flow %
-7.65%
Top 10 Hldgs %
22.05%
Holding
208
New
41
Increased
45
Reduced
65
Closed
36

Sector Composition

Rank Sector Weight
1 Technology 27.55%
2 Financials 15.23%
3 Healthcare 12.36%
4 Communication Services 12.32%
5 Industrials 11.57%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
KURA icon
151
Kura Oncology
KURA
$964M
$234K 0.16%
7,642
-37,066
-83% -$818K
TRU icon
152
TransUnion
TRU
$15.4B
$230K 0.16%
2,728
FICO icon
153
Fair Isaac
FICO
$29.2B
$228K 0.16%
536
CLLS
154
Cellectis
CLLS
$265M
$224K 0.16%
12,103
-5,948
-33% -$106K
BWMX icon
155
Betterware México
BWMX
$683M
$223K 0.16%
+12,267
New +$199K
ZGNX
156
DELISTED
Zogenix, Inc.
ZGNX
$222K 0.16%
12,392
+2,832
+30% +$69.4K
WHLRP
157
Wheeler Real Estate Investment Trust Preferred Stock
WHLRP
-23,037
Closed -$219K
EB
158
DELISTED
Eventbrite
EB
$204K 0.14%
18,756
ELF icon
159
e.l.f. Beauty
ELF
$4.34B
$199K 0.14%
11,600
+500
+5% +$9.46K
ORGO icon
160
Organogenesis Holdings
ORGO
$337M
$171K 0.12%
44,485
+9,714
+28% +$38.4K
TLYS icon
161
Tilly's
TLYS
$121M
$169K 0.12%
+28,000
New +$176K
BV icon
162
BrightView Holdings
BV
$1.35B
$160K 0.11%
14,000
TVRD
163
Tvardi Therapeutics
TVRD
$30M
$156K 0.11%
+341
New +$198K
AMRX icon
164
Amneal Pharmaceuticals
AMRX
$5.7B
$132K 0.09%
+33,874
New +$145K
KZR
165
DELISTED
Kezar Life Sciences
KZR
$116K 0.08%
+2,390
New +$114K
DNTH icon
166
Dianthus Therapeutics
DNTH
$5.77B
$109K 0.08%
1,006
+317
+46% +$37.6K
CHEF icon
167
CALL
Chefs' Warehouse
CHEF
$3.96B
$97K 0.07%
6,700
+5,700
+570% +$81.1K
GYRE icon
168
Gyre Therapeutics
GYRE
$675M
$87K 0.06%
2,686
+521
+24% +$20.4K
ADMA icon
169
ADMA Biologics
ADMA
$2.02B
$84K 0.06%
35,337
-49,459
-58% -$136K
EVFM
170
DELISTED
Evofem Biosciences, Inc. Common Stock
EVFM
$39K 0.03%
1,100
-685
-38% -$29.8K
APEN
171
DELISTED
Apollo Endosurgery, Inc.
APEN
$33K 0.02%
19,743
-4,709
-19% -$7.1K
MITO
172
DELISTED
Stealth BioTherapeutics Corp. ADS
MITO
$23K 0.02%
16,773
-4,615
-22% -$7.9K
RETA
173
CALL
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
$10K 0.01%
+100
New +$12.5K
ABBV icon
174
AbbVie
ABBV
$450B
-6,307
Closed -$619K
ACRE
175
Ares Commercial Real Estate
ACRE
$256M
-99,846
Closed -$911K

Similar funds

PA Capital's Q3 2020 Portfolio in Review

As of Q3 2020, PA Capital held 208 positions worth $142M, up 3.1% from $138M the previous quarter. Its ten largest holdings account for 22% of the portfolio.

PA Capital withdrew a net $10.9M in Q3 2020, closing 36 positions and reducing 65 holdings. Its most notable exit was ZYNGA INC. CL A COMMON, an estimated $1.25M position sold in full.

By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 27% a quarter earlier, followed by Financials and Healthcare.

Against the trend, PA Capital opened a new position in Pershing Square Tontine Holdings, Ltd. worth $1.47M.

  • PA Capital's largest Q3 2020 buy was Pershing Square Tontine Holdings, Ltd.: 69,371 shares worth $1.47M.
  • PA Capital added most to Fiserv Inc in Q3 2020, an estimated $1.15M increase.
  • PA Capital's biggest Q3 2020 reduction was At Home Group Inc., cutting an estimated $6.26M.
  • PA Capital fully exited ZYNGA INC. CL A COMMON in Q3 2020, selling an estimated $1.25M.
  • PA Capital's ten largest holdings make up 22% of its $142M portfolio in Q3 2020.
  • PA Capital opened 41 new positions and closed 36 in Q3 2020.
  • PA Capital's portfolio value rose 3.1% quarter-over-quarter to $142M.

Based on PA Capital's 13F filing for Q3 2020, filed 13 Nov 2020.